OM vs RARE · rev $59.5M vs rev $350.0M
Outset Medical Inc (OM) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Outset Medical Inc (OM) is a medical devices company listed on NASDAQ.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported OM revenue for 2026-06-30 was $59.5M. Net income was -$37.0M. OM currently screens at market cap $74.5M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
OM currently screens at market cap $74.5M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the OM and RARE stock pages for the full models.
Not investment advice.